Equity
Direct
Sector - Healthcare
NAV as on 13-03-2025
₹ 515.24
1D
Inception Returns
17.8%
/yr
Nippon India Pharma Fund Direct Growth is an equity fund. This fund was started on 1 January, 2013. The fund is managed by Kinjal Desai, Sailesh Raj Bhan. The fund could potentially beat inflation in the long-run.
Nippon India Pharma Fund Direct Growth has given a CAGR return of 17.82% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 12.49%, 18.45% and 26.94% respectively.
Nippon India Pharma Fund Direct Growth has allocated its funds majorly in Health, Cash Equivalent. Its top holdings are Sun Pharmaceuticals Industries Ltd, Divi's Laboratories Ltd, Lupin Ltd, Cipla Ltd, Dr Reddy's Laboratories Ltd
As it is a sector - healthcare mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 20%For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefitDividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.
The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.
Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 100.00. Nippon India Pharma Fund Direct Growth has no lock in period.
Expense ratio | 0.91% |
Benchmark | S&P BSE Healthcare PR |
AUM | ₹7637 Cr |
Inception Date | 1 January, 2013 |
Min Lumpsum/SIP | ₹5000/₹100 |
Exit Load | 1.0% |
Lock In | No Lock-in |
TurnOver | 16.09% |
STCG | Selling mutual fund before 1 year, returns taxed at 20%. |
LTCG | After 1 year, 12.5% tax on returns over ₹1.25 lakh/year. |
Risk | Very High Risk |
as on (13-Mar-25)
as on (31-Jan-25)
Top Sector in February was Health
Nippon India Pharma Fund Direct Growth | Absolute Returns | CAGR Returns |
1 Month Returns | -2.24% | -2.24% |
6 Month Returns | -11.73% | -11.73% |
1 Year Returns | 12.49% | 12.49% |
3 Years Returns | 66.2% | 18.45% |
5 Years Returns | 229.6% | 26.94% |
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
Nippon India Pharma Fund Direct Growth | -3 | 0.8 | 1.78 |
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
Nippon India Pharma Fund Direct Growth | 0.88 | 0.91 | 0.93 |
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
Nippon India Pharma Fund Direct Growth | 0.03 | 0.77 | 0.97 |
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
Nippon India Pharma Fund Direct Growth | 17.05 | 15.64 | 19.44 |